$QSI

Quantum-Si regains Nasdaq minimum bid price compliance (QSI:NASDAQ)

Quantum-Si (QSI) announced it has met Nasdaq's minimum bid price requirement, with its share price staying above $1 for 10 consecutive days. The company's shares fell 1.42% on the news. Quantum-Si previously reported a GAAP EPS of -$0.11 and revenue of $0.34M, both beating estimates.

Original reporting
Published Oct 15, 2026, 1:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 1:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$QSI
Bullish
high confidence
Mentioned
$QSI
Relevance
6/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$QSIBullishLow
01

Why it matters

Regaining compliance eliminates the immediate threat of a delisting notice, which can stabilize the share price and may attract short‑term buying interest.

02

Market read

The news is a primary corporate‑action disclosure for QSI, removing a listing risk and offering a modest positive catalyst for the stock.

03

What to watch

The company's upcoming Proteus launch shift and modest revenue figures could continue to pressure the stock despite compliance.

Relevance 6/10Novelty 5/10Timing: today

Background

Quantum‑Si (QSI) is a micro‑cap semiconductor firm listed on Nasdaq. Maintaining a $1 minimum bid price is required for continued listing on the Nasdaq Global Market.

Company-level read

Ticker impact

$QSIBullishHigh confidence
Context

Quantum‑Si announced it has regained Nasdaq minimum bid price compliance after its share price stayed at or above $1 for 10 consecutive days.

Expected impact

likely modest upside as investors view compliance restoration favorably

Evidence & confidence

The news is a primary corporate‑action disclosure; the compliance issue was previously a risk factor, and its removal typically yields a short‑term price lift.

Market effects

Minimal; compliance news is specific to Quantum‑Si and does not affect the broader semiconductor sector.

Limited to U.S. small‑cap investors tracking Nasdaq compliance issues.

Low; the event is company‑specific with no macro implications.

Counterpoint

Some investors may view the compliance regain as a short‑term fix that does not address underlying business challenges, suggesting caution.

Key entities

  • Quantum‑Si

    Nasdaq‑listed semiconductor company (ticker QSI).

Related articles

$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

$QSIMed

Quantum-Si Q2 Earnings Call Highlights

Quantum-Si (NASDAQ:QSI) reported Q2 2026 revenue of $344,000, down from $591,000 a year earlier, and a Q2 net loss of $23.5 million. The company said Proteus launch timing is revised to early 2027, with initial detection of 19 or 20 amino acids. It expects about $12 million annual operating-expense savings and full-year 2026 revenue near $1 million.

$QSIMedAI 8/10

Quantum-Si (QSI) Stock Falls on Q2 2026 Earnings

Quantum-Si Inc. (QSI) reported Q2 2026 revenue of $344,000, above an analyst estimate of $305,020. Diluted EPS was -$0.11, slightly better than expected. The company posted gross profit of $172,000 and an operating loss of $25.6 million, with net loss of $23.5 million. Cash was $23.7 million. Shares fell 1.19% after the release.

$QSIMed

Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update

Quantum-Si Inc (QSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new mark